Assessing Liver Fibrosis Using 2D-SWE Liver Ultrasound Elastography and Dynamic Liver Scintigraphy with 99mTc-mebrofenin: A Comparative Prospective Single-Center Study

<i>Background and Objectives:</i> Many quantitative imaging modalities are available that quantify chronic liver disease, although only a few of them are included in clinical guidelines. Many more imaging options are still competing to find their place in the area of diagnosing chronic l...

Full description

Bibliographic Details
Main Authors: Donatas Jocius, Donatas Vajauskas, Artūras Samuilis, Kipras Mikelis, Skirmante Jokubauskiene, Kestutis Strupas, Algirdas E. Tamosiunas
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/59/3/479
_version_ 1797610311822344192
author Donatas Jocius
Donatas Vajauskas
Artūras Samuilis
Kipras Mikelis
Skirmante Jokubauskiene
Kestutis Strupas
Algirdas E. Tamosiunas
author_facet Donatas Jocius
Donatas Vajauskas
Artūras Samuilis
Kipras Mikelis
Skirmante Jokubauskiene
Kestutis Strupas
Algirdas E. Tamosiunas
author_sort Donatas Jocius
collection DOAJ
description <i>Background and Objectives:</i> Many quantitative imaging modalities are available that quantify chronic liver disease, although only a few of them are included in clinical guidelines. Many more imaging options are still competing to find their place in the area of diagnosing chronic liver disease. We report our first prospective single-center study evaluating different imaging modalities that stratify viral hepatitis-associated liver fibrosis in a treatment-naïve patient group. <i>Materials and Methods:</i> The aim of our study is to compare and to combine already employed 2D shear wave elastography (2D-SWE) with dynamic liver scintigraphy with 99mTc-mebrofenin in chronic viral hepatitis patients for the staging of liver fibrosis. <i>Results:</i> Seventy-two patients were enrolled in the study. We found that both 2D-SWE ultrasound imaging, with dynamic liver scintigraphy with 99mTc-mebrofenin are able to stratify CLD patients into different liver fibrosis categories based on histological examination findings. We did not find any statistically significant difference between these imaging options, which means that dynamic liver scintigraphy with 99mTc-mebrofenin is not an inferior imaging technique. A combination of these imaging modalities showed increased accuracy in the non-invasive staging of liver cirrhosis. <i>Conclusions:</i> Our study presents that 2D-SWE and dynamic liver scintigraphy with 99mTc-mebrofenin could be used for staging liver fibrosis, both in singular application and in a combined way, adding a potential supplementary value that represents different aspects of liver fibrosis in CLD.
first_indexed 2024-03-11T06:12:41Z
format Article
id doaj.art-cfc222bc159445abaf7338890f0ef4e6
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-11T06:12:41Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-cfc222bc159445abaf7338890f0ef4e62023-11-17T12:31:13ZengMDPI AGMedicina1010-660X1648-91442023-02-0159347910.3390/medicina59030479Assessing Liver Fibrosis Using 2D-SWE Liver Ultrasound Elastography and Dynamic Liver Scintigraphy with 99mTc-mebrofenin: A Comparative Prospective Single-Center StudyDonatas Jocius0Donatas Vajauskas1Artūras Samuilis2Kipras Mikelis3Skirmante Jokubauskiene4Kestutis Strupas5Algirdas E. Tamosiunas6Department of Radiology, Nuclear Medicine and Medical Physics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, LT-01513 Vilnius, LithuaniaDepartment of Radiology, Medical Academy, Lithuanian University of Health Science Kauno Klinikos, LT-44307 Kaunas, LithuaniaDepartment of Radiology, Nuclear Medicine and Medical Physics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, LT-01513 Vilnius, LithuaniaDepartment of Radiology, Nuclear Medicine and Medical Physics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, LT-01513 Vilnius, LithuaniaNational Center of Pathology, LT-01513 Vilnius, LithuaniaClinic of Gastroenterology, Nephro-Urology and Surgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, LT-01513 Vilnius, LithuaniaDepartment of Radiology, Nuclear Medicine and Medical Physics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, LT-01513 Vilnius, Lithuania<i>Background and Objectives:</i> Many quantitative imaging modalities are available that quantify chronic liver disease, although only a few of them are included in clinical guidelines. Many more imaging options are still competing to find their place in the area of diagnosing chronic liver disease. We report our first prospective single-center study evaluating different imaging modalities that stratify viral hepatitis-associated liver fibrosis in a treatment-naïve patient group. <i>Materials and Methods:</i> The aim of our study is to compare and to combine already employed 2D shear wave elastography (2D-SWE) with dynamic liver scintigraphy with 99mTc-mebrofenin in chronic viral hepatitis patients for the staging of liver fibrosis. <i>Results:</i> Seventy-two patients were enrolled in the study. We found that both 2D-SWE ultrasound imaging, with dynamic liver scintigraphy with 99mTc-mebrofenin are able to stratify CLD patients into different liver fibrosis categories based on histological examination findings. We did not find any statistically significant difference between these imaging options, which means that dynamic liver scintigraphy with 99mTc-mebrofenin is not an inferior imaging technique. A combination of these imaging modalities showed increased accuracy in the non-invasive staging of liver cirrhosis. <i>Conclusions:</i> Our study presents that 2D-SWE and dynamic liver scintigraphy with 99mTc-mebrofenin could be used for staging liver fibrosis, both in singular application and in a combined way, adding a potential supplementary value that represents different aspects of liver fibrosis in CLD.https://www.mdpi.com/1648-9144/59/3/479chronic liver diseaseliver fibrosisultrasound elastographydynamic liver scintigraphy99mTc-mebrofenin
spellingShingle Donatas Jocius
Donatas Vajauskas
Artūras Samuilis
Kipras Mikelis
Skirmante Jokubauskiene
Kestutis Strupas
Algirdas E. Tamosiunas
Assessing Liver Fibrosis Using 2D-SWE Liver Ultrasound Elastography and Dynamic Liver Scintigraphy with 99mTc-mebrofenin: A Comparative Prospective Single-Center Study
Medicina
chronic liver disease
liver fibrosis
ultrasound elastography
dynamic liver scintigraphy
99mTc-mebrofenin
title Assessing Liver Fibrosis Using 2D-SWE Liver Ultrasound Elastography and Dynamic Liver Scintigraphy with 99mTc-mebrofenin: A Comparative Prospective Single-Center Study
title_full Assessing Liver Fibrosis Using 2D-SWE Liver Ultrasound Elastography and Dynamic Liver Scintigraphy with 99mTc-mebrofenin: A Comparative Prospective Single-Center Study
title_fullStr Assessing Liver Fibrosis Using 2D-SWE Liver Ultrasound Elastography and Dynamic Liver Scintigraphy with 99mTc-mebrofenin: A Comparative Prospective Single-Center Study
title_full_unstemmed Assessing Liver Fibrosis Using 2D-SWE Liver Ultrasound Elastography and Dynamic Liver Scintigraphy with 99mTc-mebrofenin: A Comparative Prospective Single-Center Study
title_short Assessing Liver Fibrosis Using 2D-SWE Liver Ultrasound Elastography and Dynamic Liver Scintigraphy with 99mTc-mebrofenin: A Comparative Prospective Single-Center Study
title_sort assessing liver fibrosis using 2d swe liver ultrasound elastography and dynamic liver scintigraphy with 99mtc mebrofenin a comparative prospective single center study
topic chronic liver disease
liver fibrosis
ultrasound elastography
dynamic liver scintigraphy
99mTc-mebrofenin
url https://www.mdpi.com/1648-9144/59/3/479
work_keys_str_mv AT donatasjocius assessingliverfibrosisusing2dsweliverultrasoundelastographyanddynamicliverscintigraphywith99mtcmebrofeninacomparativeprospectivesinglecenterstudy
AT donatasvajauskas assessingliverfibrosisusing2dsweliverultrasoundelastographyanddynamicliverscintigraphywith99mtcmebrofeninacomparativeprospectivesinglecenterstudy
AT arturassamuilis assessingliverfibrosisusing2dsweliverultrasoundelastographyanddynamicliverscintigraphywith99mtcmebrofeninacomparativeprospectivesinglecenterstudy
AT kiprasmikelis assessingliverfibrosisusing2dsweliverultrasoundelastographyanddynamicliverscintigraphywith99mtcmebrofeninacomparativeprospectivesinglecenterstudy
AT skirmantejokubauskiene assessingliverfibrosisusing2dsweliverultrasoundelastographyanddynamicliverscintigraphywith99mtcmebrofeninacomparativeprospectivesinglecenterstudy
AT kestutisstrupas assessingliverfibrosisusing2dsweliverultrasoundelastographyanddynamicliverscintigraphywith99mtcmebrofeninacomparativeprospectivesinglecenterstudy
AT algirdasetamosiunas assessingliverfibrosisusing2dsweliverultrasoundelastographyanddynamicliverscintigraphywith99mtcmebrofeninacomparativeprospectivesinglecenterstudy